Академический Документы
Профессиональный Документы
Культура Документы
Los ttulos < 1:80 se consideran negativos. Los ttulos de 1:80 y 1:160 se consideran
positivos dbiles y en ausencia de sntomas especficos de EAS no requieren otros
estudios, aunque los pacientes deben ser controlados clnicamente. Los ttulos 1:320
se consideran positivos y se recomienda realizar estudios adicionales.
Si en los pacientes menores de 16 aos se utiliza una dilucin inferior para el cribado
de ANAs, deber especificarse en el comentario incluyendo el punto de corte
recomendado.
Comentario 2: Las pruebas negativas rara vez necesitan ser repetidas, solo si
hay una fuerte sospecha de una evolucin a EAS o un cambio en la evolucin
de la enfermedad del paciente est indicado repetir la determinacin.
Si los ANAs son positivos pero el laboratorio no puede realizar test reflejos y por
tanto no puede determinar los anti-dsDNA o ENAs se recomienda aadir el:
Autores:
Dra. Montserrat Alsina Donadeu
Dr. Victor Farr Guerrero
Fecha de creacin 21/01/2014 12:46:00
Autores:
Dra. Montserrat Alsina Donadeu
Dr. Victor Farr Guerrero
Fecha de creacin 21/01/2014 12:46:00
Bibliografia:
1. The CAP panel of representatives from CAP, ACR, CIS & CC-NIH. Guidelines for
clinical use of the antinuclear antibody test and tests for specific autoantibodies to
nuclear antigens. Arch Pathol Lab Med, 2000; 124: 71-81
2. Tozzoli R, Bizzaro N, Tonutti E, Villalta D, Bassetti D, Manoni F et al. Italian Society
of Laboratory Medicine Study Group on the Diagnosis of Autoimmune Diseases.
Guidelines for the laboratory use of autoantibody tests in the diagnosis and
monitoring of autoimmune rheumatic diseases. Am J Clin Pathol 2002; 117: 316-324
3. Solomon DH, Kavanaugh AJ, Schur PH and The American College of
Rheumatology ad hoc Committee on Immunologic Testing Guidelines. Evidencebased guidelines for the use of immunologic tests: Antinuclear antibody testing.
Arthritis Rheum (Arthritis Care Research) 2002; 47(4): 434-444
4. Arthur F. Kavanaugh, Daniel H. Solomon, AND The American College of
Rheumatology ad hoc Committee on Immunologic Testing Guidelines.Guidelines for
Immunologic Laboratory Testing in the Rheumatic Diseases: Anti-DNA Antibody
Tests. Arthur F. Kavanaugh, Arthritis & Rheumatism (Arthritis Care & Research) Vol.
47, No. 5, October 15, 2002, pp 546555.
5. Reveille JD, Solomon DH, and the American College of Rheumatology ad hoc
committee on immunologic testing guidelines. Evidence based guidelines for the use
of immunologic tests: Anticentromere, Scl-70 and nucleolar antibodies. Arthritis
Rheum 2003; 49:399-412
6. Vitali C, Bombardieri S, Jonsson R, et al.; European Study Group on Classification
Criteria for Sjogren's Syndrome. Classification criteria for Sjogren's syndrome: a
revised version of the European criteria proposed by the American-European
Consensus Group. Ann Rheum Dis. 2002 Jun;61(6):554-558
7. S. C. Shiboski, et al. American College of Rheumatology Classification Criteria for
Sjogrens Syndrome: A Data-Driven, Expert Consensus Approach in the Sjgrens
International Collaborative Clinical Alliance Cohort Arthritis Care & Research. Vol.
64, No. 4, April 2012, pp 475487
8. Michael Mahler, Reinout Raijmakers, Marvin J. Fritzler. Challenges and
Controversies in Autoantibodies Associated with Systemic. Rheumatic Diseases.
Current Rheumatology Reviews, 2007, 3, 67-78
9. J.G.M.C. Damoiseaux, J.W. Cohen Tervaert. From ANA to ENA: How to proceed?.
Autoimmunity Reviews 5 (2006) 10 17
10. M. Jos Amengual Guedn, Lourdes Mozo Avellaned, Carmen Rodrguez
Hernndez. Sociedad Espaola de Inmunologa. Protocolos de diagnstico
inmunolgico en enfermedades autoinmunes. Elsevier Doyma, 2012
11. Petri M, Orbai AM, Alarcn GS, Gordon C, et al. Derivation and validation of the
systemic lupus international collaborating clinics classification criteria for systemic
lupus erythematosus. Arthritis Rheum. 2012 Aug;64(8):2677-86. doi:
10.1002/art.34473.
12.
Autores:
Dra. Montserrat Alsina Donadeu
Dr. Victor Farr Guerrero
Fecha de creacin 21/01/2014 12:46:00
Autores:
Dra. Montserrat Alsina Donadeu
Dr. Victor Farr Guerrero
Fecha de creacin 21/01/2014 12:46:00